Study Finds No Differences in Cognitive Abilities Between Sexes
No differences in cognitive abilities were identified between men and women with Parkinson’s disease, according to a recent study.
Articles by Steve Bryson, PhD
Extended Dosing Improves Safety of IkT-148009, Animal Studies Show
The safety profile of IkT-148009, an investigational oral medication for Parkinson’s disease, improved the longer the drug was…
MJFF Details Need for Diversity in Parkinson’s Research, Care
Current understanding of Parkinson’s disease does not reflect patients from diverse socioeconomic or ethnic backgrounds, and they remain poorly…
Immune Cells Found to Cooperate to Fight Toxic Protein Clumps
Immune cells in the brain responsible for breaking down the toxic protein clumps, or aggregates, that lead to nerve cell…
SYNTap Biomarker Test to Aid Early Parkinson’s Diagnosis Available in US
Amprion has announced the commercial rollout of SYNTap Biomarker Test, a laboratory test to accurately detect alpha-synuclein aggregates,…
Vanqua Bio Will Use $85M Funding to Advance New Tech Platform
Vanqua Bio has raised $85 million in funding to accelerate the development of its small molecule technology platform for…
New Analysis Reveals Gene Activity That May Underlie Parkinson’s
Studies on twins and families have suggested that susceptibility to Parkinson’s disease has a substantial genetic component. Now, an analysis…
MJFF Offers Free Resources About ‘Off’ Time
The Michael J. Fox Foundation (MJFF) has released a new suite of free educational resources that focuses on so-called “off”…
Antioxidant Urate Fails to Slow Early Disease Progression
The antioxidant urate failed to slow Parkinson’s disease progression in newly diagnosed patients over two years, according to data…
Epilepsy Medication Use Weighs on Patients’ Quality of Life, Study Finds
People with Parkinson’s disease who use medications for epilepsy reported a poorer quality of life on questionnaires than did…